Jannis M. Muller

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Serum Glial Fibrillary Acidic Protein Dynamics, Disease Progression, and Therapy Response in Multiple Sclerosis.

Serum Glial Fibrillary Acidic Protein Dynamics, Disease Progression, and Therapy Response in Multiple Sclerosis.

Journal: JAMA neurology
Published: August 03, 2026

Retinal layers prognosticate cognitive progression independent of relapse activity in multiple sclerosis.

Retinal layers prognosticate cognitive progression independent of relapse activity in multiple sclerosis.

Journal: Journal of neurology
Published: May 27, 2026

Predicting Disability Using PIRA in Multiple Sclerosis: Is It as Straightforward as It Appears?

Predicting Disability Using PIRA in Multiple Sclerosis: Is It as Straightforward as It Appears?

Journal: Neurology
Published: September 22, 2025

Accurate quantification of steps from multiple smartphone positions.

Accurate quantification of steps from multiple smartphone positions.

Journal: Scientific reports
Published: September 18, 2025

Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody-Associated Disease.

Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody-Associated Disease.

Journal: Neurology
Published: September 04, 2025

GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis.

GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis.

Journal: Brain : a journal of neurology
Published: June 14, 2025

GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis.

GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis.

Journal: Brain : a journal of neurology
Published: June 14, 2025

White Matter Tract Degeneration in Multiple Sclerosis Patients With Progression Independent of Relapse Activity.

White Matter Tract Degeneration in Multiple Sclerosis Patients With Progression Independent of Relapse Activity.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: April 16, 2025

Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis.

Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis.

Journal: JAMA neurology
Published: April 14, 2025

Functional magnetic resonance imaging in prurigo nodularis: A call to study neural sensitization phenomena.

Functional magnetic resonance imaging in prurigo nodularis: A call to study neural sensitization phenomena.

Journal: Clinics in dermatology
Published: March 16, 2025

Incidence of multiple sclerosis in Switzerland - results from the Swiss multiple sclerosis registry.

Incidence of multiple sclerosis in Switzerland - results from the Swiss multiple sclerosis registry.

Journal: Multiple sclerosis and related disorders
Published: March 10, 2025

Fluid and White Matter Suppression contrasts MRI improves Deep Learning detection of Multiple Sclerosis Cortical Lesions.

Fluid and White Matter Suppression contrasts MRI improves Deep Learning detection of Multiple Sclerosis Cortical Lesions.

Journal: NeuroImage. Clinical
Published: January 21, 2025
Showing 1-12 of 33

Last Updated: 09/26/2026